Speaking Faculty

Aris Persidis, Ph.D.President, Biovista

Clare Thibodeaux, Ph.D.Director of Scientific Affairs, Cures Within Reach

Dr. Bruce BloomFounder, Cures Within Reach, Chief Collaboration Officer, Healx

Laura Kleiman, Ph.D.Founder & CEO, Reboot Rx

Matthew Fedowitz, JDShareholder, Buchanan Ingersoll & Rooney

John SemanChief Executive Officer, Revitale Pharma

Santiago Ramon-Garcia, Ph.D.ARAID Investigator, Research and Development Agency of Aragon (ARAID) Foundation

James Doyle, Ph.D.Co-Founder and CEO, Modelis

Andrew Reaume, Ph.D., MBAPresident & CEO, Co-Founder, Melior Discovery

Stephen CaseyFounder & CEO, The 505(b)(2) Platform

Michael DerbyManaging Partner, TardiMed Sciences

Heather Mortiboys, Ph.D.Senior Lecturer, Associate Professor, University of Sheffield

David H. Crean, Ph.D., MBAPresident & CEO, Coast Bioventures

Malina Bakowski, Ph.D.Principal Investigator, Calibr at Scripps Research

Richard Wyse, MDDirector of Research & Development, Cure Parkinson's Trust

Sven Jacobson, MBACEO, Woolsey Pharmaceuticals, Co-Founder & CEO, Martin Pharmaceuticals

OM Sharma, Ph.D.Vice President, Bioinformatics, Innoplexus

Marco Schito, Ph.D.Executive Director, CURE Drug Repurposing Collaboratory (CDRC), Critical Path Institute

Rachel RubinVice President for Programs, Roivant Social Ventures